Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 18 Source: CRO
- €20 million turnover
-
€32.5 million
profit - 52 employees
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
- 3 more years available »
Ranking
By Turnover
(€20 million)- 883rd in Top Companies
- 95th in Health
By Employees
(52)- 829th in Top Companies
- 89th in Health
- 52
- €20 million
Employees
- Colm Healy Vice President}
Latest News
- Aug 10 F1 revenues almost wiped out by pandemic halt to races
- Aug 10 Bank and energy stocks lift European markets
- Aug 10 Unilever would scrap HQ move if Dutch ‘exit tax’ law enacted
- Aug 10 ‘No demand... because there are no people’ at well-known Dublin pub
- Aug 10 Foot Locker defies Wall St with profit during Covid quarter